Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)

Thorax

Volumn 65, Issue 7, 2010, Pages 645-651

  Nguyen Van Tam, J S ^a   Openshaw, P J M ^b   Hashim, A ^a   Gadd, E M ^c   Lim, W S ^d   Semple, M G ^e   Read, R C ^f   Taylor, B L ^g   Brett, S J ^h   McMenamin, J ⁱ   Enstone, J E ^a   Armstrong, C ^c   Nicholson, K G ^j  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c Skipton House ^*  (United Kingdom)

^d NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f UNIVERSITY OF SHEFFIELD   (United Kingdom)

^g PORTSMOUTH HOSPITALS NHS TRUST   (United Kingdom)

^h IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

ⁱ HEALTH PROTECTION SCOTLAND   (United Kingdom)

^j LEICESTER ROYAL INFIRMARY   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; C REACTIVE PROTEIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASTHMA; BACTERIAL INFECTION; CHILD; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNICITY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFANT; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIXED INFECTION; MORTALITY; MULTIVARIATE ANALYSIS; NORTH AMERICA; OBESITY; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; PHYSICIAN; PNEUMONIA; PREGNANT WOMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SCHOOL CHILD; THORAX RADIOGRAPHY; UNITED KINGDOM; AGE; CLINICAL TRIAL; EPIDEMIC; INFLUENZA; INTENSIVE CARE; LENGTH OF STAY; MIDDLE AGED; MULTICENTER STUDY; PROGNOSIS; STATISTICS; TREATMENT OUTCOME; UTILIZATION REVIEW; VIROLOGY; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CRITICAL CARE; DISEASE OUTBREAKS; ENGLAND; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA, VIRAL; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955286120     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.135210     Document Type: Article

References (35)

1. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009;361:680-9.
2. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-15. [Erratum: N Engl J Med 2009;361:102.]
3. Garske T, Legrand J, Donnelly CA, et al. Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ 2009;339:b2840.
4. Vaillant L, La Ruche G, Tarantola A, et al. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009;14:pii=19309. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19309 (accessed 19 Oct 2009).
5. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, HPA Northern Ireland Swine Influenza Investigation Teams. Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April-June 2009. Euro Surveill 2009;14:pii=19232. http://www.eurosurveillance. org/ViewArticle.aspx?ArticleId=19232 (accessed 19 Oct 2009).
6. Gilsdorf A, Poggensee G. Working Group Pandemic Influenza A(H1N1)v. Influenza A (H1N1)v in Germany: the first 10,000 cases. Euro Surveill 2009;14:pii=19318. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId= 19318 (accessed 19 Oct 2009).
7. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361;1935-44.
8. Centers for Disease Control and Prevention. Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. MMWR Morb Mortal Wkly Rep 2009;58:536-41.
9. Anon. Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec 2009;84:185-9.
10. Anon. Human infection with new influenza A (H1N1) virus: clinical observations in hospitalized patients, Americas, July 2009 - update. Wkly Epidemiol Rec 2009;84:305-8.
11. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009;374:451-8.
12. Denholm JT, Gordon CL, Johnson PD, et al. Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. Med J Aust 2010;192:1-3.
13. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.JAMA2009;302:1896-902.
14. Rusconi F, Castagneto M, Gagliardi L, et al. Reference values for respiratory rate in the first 3 years of life. Pediatrics 1994;94:350-5. (Pubitemid 24271479)
15. Wallis LA, Healy M, Undy MB, et al. Age related reference ranges for respiration rate and heart rate from 4 to 16 years. Arch Dis Child 2005;90:1117-21. (Pubitemid 41565267)
16. American Heart Association in collaboration with International Liaison Committee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2000;102(Suppl):I1-I384.
17. Thompson M, Harnden A, Perera R, et al. Deriving temperature and age appropriate heart rate centiles for children with acute infections. Arch Dis Child 2009;94:361-5.
18. O'Driscoll BR, Howard LS, Davison AG. BTS guideline for emergency oxygen use in adult patients. Thorax 2008;63(Suppl 6):vi1-68. [Erratum: Thorax 2009;64:91].
19. British Infection Society, British Thoracic Society, Health Protection Agency. Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society and Health Protection Agency in collaboration with the Department of Health. Thorax 2007;62(Suppl 1):1-46.
20. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009;361:1945-52.
21. Donaldson LJ, Rutter PD, Ellis BM, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009;339:b5213.
22. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009 July 31/58(Early Release);1-52. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr58e0724a1.htm (accessed 18 Nov 2009).
23. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008;359:1555-64.
24. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009;302:1872-9.
25. Centers for Disease Control and Prevention. Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009;58:749-52.
26. Keshet R, Boursi B, Maoz R, et al. Diagnostic and prognostic significance of serum C-reactive protein levels in patients admitted to the department of medicine. Am J Med Sci 2009;337:248-55.
27. Estenssoro E, Rios FG, Apeztegula C, et al. Pandemic 2009 influenza A(H1N1) in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med 2010. [Epub 2010 Mar 4].
28. Centers for Disease Control and Prevention. Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection - United States, April -August 2009. MMWR Morb Mortal Wkly Rep 2009;58:941-7.
29. Centers for Disease Control and Prevention. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) virus infection - United States, May - August 2009. MMWR Morb Mortal Wkly Rep 2009;58:1071-4.
30. The ANZIC Influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;361:1925-34.
31. Baker MG, Wilson N, Huang QS, et al. Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill 2009;14:1-6. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19319 (accessed 14 Jan 2010).
32. Rice GW, Palmer E. Pandemic influenza in Japan, 1918-19: mortality patterns and official responses. J Jpn Stud 1993;19:389-420.
33. Falagas ME, Vouloumanou EK, Baskouta E, et al. Treatment options for 2009 H1N1 influenza: evaluation of the published evidence. Int J Antimicrob Agents 2010;35:421-30.
34. Institut de Veille Sanitaire. Intérêt d'un traitement précoce par antiviral pour réduire la sévé rité et la mortalité par grippe A(H1N1)2009: données issues de la surveillance des formes graves. [French]. http://www.invs.sante.fr/ surveillance/grippe-dossier/docs-professionnels/antiviraux-grippe-a-h1n1-211209. pdf (accessed 25 Mar 2010).
35. Zarychanski R, Stuart TL, Kumar A. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) infection. CMAJ 2010;182:257-64.